![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Combimatrix Corp. (MM) | NASDAQ:CBMX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.25 | 0.05 | 6.75 | 0 | 01:00:00 |
The letter from Nasdaq said that based on the Company's Form 10-Q for the period ended June 30, 2013, which evidenced stockholders' equity of $5.7 million, the Nasdaq Staff has determined that CombiMatrix complies with the Rule and "the matter is now closed."
There can be no assurance, however, that the Company will be able to maintain compliance long-term with Nasdaq requirements for continued listing.
About CombiMatrix Corporation
CombiMatrix Corporation provides valuable molecular diagnostic solutions and comprehensive clinical support for the highest quality of care – specializing in miscarriage analysis, prenatal and pediatric healthcare. CombiMatrix offers comprehensive testing services for the detection of genetic abnormalities at the DNA level, beyond what can be identified through traditional methodologies. The Company performs genetic testing utilizing advanced technologies, including microarray, FISH, PCR and G-Band chromosome analyses. Additional information about CombiMatrix is available at www.combimatrix.com or by calling 1-800-710-0624.
CONTACT: Company Contact: Mark McDonough President & CEO, CombiMatrix Corporation Tel (949) 753-0624 Media Contact: Len Hall VP, Media Relations Allen & Caron Tel (949) 474-4300 len@allencaron.com Investor Relations Contact: John Baldissera BPC Financial Marketing Tel (800) 368-1217
1 Year Combimatrix Corp. (MM) Chart |
1 Month Combimatrix Corp. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions